Navigation Links
Neogen Named to Fortune's List of Fastest Growing Companies

LANSING, Mich., July 9 /PRNewswire-FirstCall/ -- Fortune Magazine has named Neogen Corporation (Nasdaq: NEOG) as a selection in its annual list of America's 100 fastest growing small public companies (FSB 100).

In announcing its FSB 100 for 2009, Fortune stated: "In good times the FSB 100 constitutes an elite group of small public companies: the best of the best, measured by revenue growth and stock performance over the past three years. But in this Great Recession, their performance is nothing short of miraculous."

"We are very pleased that this respected financial publication has once again recognized our company's financial performance as one of the best in America," said James Herbert, Neogen's CEO. "In the financial community, as well as in our food and animal safety industry, trust is earned. We're extremely proud of the trust we've earned from our customers and investors to make this recognition possible."

In making its selection, Fortune said: "Consider Neogen (number 21 on the list), a firm that specializes in products designed to enhance food safety. Food crises, involving everything from bum lettuce to tainted peanut butter, have occurred with alarming frequency of late. Based in Lansing, Mich., Neogen supplies large foodmakers with detection kits that allow them to self-test for contaminants and allergens, helping prevent mistakes that could lead to deadly consequences."

In addition to its number 21 ranking on the FSB 100 list, Fortune featured Neogen as one of five companies "Thriving In Hard Times." Fortune's ninth annual list of the fastest-growing small public companies in America includes U.S.-based firms with annual revenues of less than $200 million and a stock price greater than $1.

Neogen to announce FY 2009 results on Tuesday, July 21

Neogen has scheduled the release of results for its 2009 fiscal year, which ended May 31, for prior to market opening on Tuesday, July 21. Neogen CEO James Herbert and President Lon Bohannon will host a conference call at 11 a.m. ET that day to discuss Neogen's performance for the previous fiscal year, as well as provide some perspective on the company's strategies for future growth. Web links will be available at to listen to the call live, or access an audio file of the call at a later date.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.

SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Named to Fortunes List of 40 Stocks To Retire On
2. Neogen Partners With Chinese Government
3. Neogen Develops Quickest Single Test for Beta-Lactams and Tetracyclines in Milk
4. Neogen Reports Record Third Quarter
5. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results Conference Call
6. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
7. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
8. Neogen Names New Senior Science Officer; Added to S&P Index
9. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
10. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
11. Neogen Reports Best Quarter in Its 26-Year History
Post Your Comments:
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... la première fois les différences entre les souches ... de celles des êtres humains . Ces ... comprendre et envisager la prise en charge efficace de ... ent diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):